---
title: "NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297649436.md"
description: "NorthStrive Biosciences has broadened its AI-driven drug discovery program in partnership with Yuva Biosciences. They are progressing four newly discovered compounds through AI toward lead nomination."
datetime: "2026-09-01T11:46:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297649436.md)
  - [en](https://longbridge.com/en/news/297649436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297649436.md)
generator: "portal-rs"
---

# NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications

NorthStrive Biosciences has broadened its AI-driven drug discovery program in partnership with Yuva Biosciences. They are progressing four newly discovered compounds through AI toward lead nomination.

## Related News & Research

- [Vibra Energia launches BRL 1.4 billion unsecured debenture offering](https://longbridge.com/en/news/298116619.md)
- [17:06 ETMorpho UV Printer Unveiled at IFA with Hands-On Live Creation](https://longbridge.com/en/news/298117780.md)
- [Signant Health, Lothar Medical sign LOI to bring ALDS PRO respiratory assessment system to clinical trials](https://longbridge.com/en/news/298112789.md)
- [Goldman Sachs Reaffirms Their Buy Rating on Watches of Switzerland Group PLC (WOSG)](https://longbridge.com/en/news/298111841.md)
- [OpenAI acknowledges 'wiki incident' and need for more transparency around unintended AI behavior](https://longbridge.com/en/news/298113378.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**